NSE filing, NSE: ZENITHDRUG. Summary written from the filing by ALFA Finder's alert engine.
Zenith Drugs Ltd: key numbers
- Share price
- ₹37.00
- Market cap
- ₹63.45 Cr
- Revenue (annual)
- ₹171.2 Cr
- Net profit (annual)
- ₹3.94 Cr
- P/E (TTM)
- 16.1×Sector 45.9×
- Promoter holding
- 69.98%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zenith Drugs Ltd
All →Zenith Drugs Bags ₹0.73 Cr Order from Uttar Pradesh Medical Supplies Corporation Limited
Zenith Drugs won a tender from Uttar Pradesh Medical Supplies Corporation for Betamethasone Valerate cream. The ₹0.73 Crore contract value strengthens the company's pharmaceutical supply pipeline.
- Value
- ₹0.73 Cr
- From
- Uttar Pradesh Medical Supplies Corporation Limited
Zenith Drugs Business Update
Zenith Drugs Board approved sale of a 5-hectare property in Indore for ₹13.75 Crore to ACE Engineering & Chemicals Pvt Ltd. Completion expected by November 2026.
- Value
- ₹13.75 Cr
Zenith Drugs Bags New Order from Haryana Medical Services Corporation Limited
Zenith Drugs Limited has been awarded a tender by Haryana Medical Services Corporation Limited to supply medicines for two years at Rs. 11.15 per unit.
- From
- Haryana Medical Services Corporation Limited
- Execution
- 2 years
Zenith Drugs Annual General Meeting
Zenith Drugs Limited released the voting results and Scrutinizer's Report for its 26th Annual General Meeting conducted on September 29, 2026.
Zenith Drugs Annual General Meeting
Zenith Drugs Limited has issued a notice for its 26th Annual General Meeting scheduled for September 29, 2026, to transact various ordinary and special business.
Zenith Drugs Board Meeting Outcome
Zenith Drugs Limited announced the notice for its 26th AGM and appointed a secretarial auditor and a scrutinizer for the meeting.
Other other announcement announcements
All →Chemkart India Other Announcement
Chemkart India reported no IPO fund deviation for the half year ended 30 September 2026. Rs.39.48 Crore of Rs.64.47 Crore allocation is utilised.
Zee Entertainment Enterprises Other Announcement
Zee Entertainment updated its authorised KMP list for Reg 30 disclosures, effective 2 November 2026, after a Company Secretary change. No money or business event is involved.
Pranav Constructions Other Announcement
Pranav Constructions filed Crisil's monitoring agency report on IPO proceeds for the quarter ended September 2026. It reports no deviation from the issue objects.
Tempsens Instruments (India) Other Announcement
Tempsens Instruments reported no deviation in IPO fund utilisation for the quarter ended 30 September 2026. This is a routine Regulation 32 statement.
GMR Power and Urban Infra Other Announcement
GMR Power filed a monitoring agency report for the quarter ended September 30, 2026. Preferential issue proceeds are fully utilised, with no deviation from the offer document.
Sanwaria Consumer Other Announcement
Sanwaria Consumer certified delivery of share certificates within 30 days for April to September 2026 under Regulation 40(9). It is a routine half-yearly compliance certificate with no financial impact.